<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Postgrad Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Postgrad Med</journal-id>
      <journal-id journal-id-type="publisher-id">JPGM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Postgraduate Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-3859</issn>
      <issn pub-type="epub">0972-2823</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27089112</article-id>
      <article-id pub-id-type="pmc">4944349</article-id>
      <article-id pub-id-type="publisher-id">JPGM-62-136</article-id>
      <article-id pub-id-type="doi">10.4103/0022-3859.180577</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tumefactive demyelination following herbal supplement use: Cause or coincidence?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dubey</surname>
            <given-names>D</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Golden</surname>
            <given-names>E</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suss</surname>
            <given-names>A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cano</surname>
            <given-names>CA</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krishnan</surname>
            <given-names>G</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stuve</surname>
            <given-names>O</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Divyanshu Dubey, E-mail: <email xlink:href="divyanshudubey87@gmail.com">divyanshudubey87@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2016</year>
      </pub-date>
      <volume>62</volume>
      <issue>2</issue>
      <fpage>136</fpage>
      <lpage>137</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2016 Journal of Postgraduate Medicine</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Sir,</p>
    <p>A 32-year-old male presented with right-sided facial droop (lower-half) and dysarthria. He reported onset of speech changes approximately 1 week prior to presentation. On the day of presentation he noticed the right-sided facial droop. He reported rhinorrhea and mild cough 1 week prior to the onset of dysarthria as well. On a detailed review of his dietary and medication history the patient reported taking an herbal medication called Hyland Restful Legs<sup>&#xAE;</sup> for restless leg syndrome for the last 6 weeks.</p>
    <p>Magnetic resonance imaging (MRI) brain with contrast showed three open ring-enhancing lesions, one within the right parietal lobe and two located within the left frontoparietal lobe [Figure <xref ref-type="fig" rid="F1">1a</xref> and <xref ref-type="fig" rid="F1">b</xref>]. On T2-weighted images a hypointense rim surrounding the large right parietal lesion was also seen [<xref ref-type="fig" rid="F1">Figure 1c</xref>]. MRI spine was unremarkable. Magnetic resonance (MR) spectroscopy with voxels over the left frontoparietal lobe lesion showed minimally decreased 1-naphthaleneacetic acid (NAA) levels and minimally increased choline without any significant decrease in the NAA/choline ratio. This combination of decreased NAA and increased choline was considered to be consistent with the acute phase of a demyelination. Cerebrospinal fluid (CSF) protein, total nucleated cells, oligoclonal bands, IgG synthesis rate, IgG index, and CSF flowcytometry were unremarkable. Based on the clinical presentation and the appearance of the lesions on MRI diagnosis of Tumefactive demyelinating lesions (TDLs) was made. The patient was initiated on 1 g methylprednisolone daily for 5 days. MRI brain brain obtained following completion of high dose corticosteroids showed minimal enlargement of ring enhancing lesion [<xref ref-type="fig" rid="F1">Figure 1d</xref>]. Patient received five sessions of plasmapheresis with complete resolution of clinical symptoms. A causal relationship between treatment with herbal supplement and TDL is possible, as there is a close temporal relationship between its oral administration and onset of neurological symptoms. Other investigators previously reported the occurrence of acute disseminated encephalomyelitis (ADEM) following the administration of plant extracts (echinacea angustifolia D2, aconitum D4, lachesis D8).[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>]</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Serial brain MRI scans of the patient. First MRI of brain on presentation showed gadolinium-enhancing lesions (a and b) and a T2 hyperintense lesions with perilesional hypontense rim (c). Second MRI of brain obtained prior to initiation of plasmapheresis showed minimal enlargement of the contrast-enhancing lesion (d)</p>
      </caption>
      <graphic xlink:href="JPGM-62-136-g001"/>
    </fig>
    <p>The supplement, Hyland Restful Legs<sup>&#xAE;</sup>, used by the patient in this study has many active ingredients including arsenicum album, lycopodium, pulsatilla, rhus toxicodendron, and zincum metallicum.[<xref rid="ref3" ref-type="bibr">3</xref>] As per the manufacturer, this medication has no major adverse effects or drug interactions, although it is opaque as to what data or assessments these statements are based on. Clearly, some of the ingredients in this herbal supplement have been associated with immune regulation. Sun <italic>et al</italic>. compared saponins from root extract of <italic>Pulsatilla chinesis</italic> with Quil A spanonins for potential adjuvant activity in mice immunized with Ovalbumin (OVA).[<xref rid="ref4" ref-type="bibr">4</xref>] These investigators identified increased OVA-specific antibody levels (IgG, IgG1, IgG2a), OVA induced splenocyte proliferation, serum TNF-&#x3B1;, and IL-2 levels in the Pulsatilla saponins treated group. These findings suggest that Pulsatilla extract may promote <italic>T</italic> helper type-1 (Th1) cell response against certain antigens.</p>
    <p>Additionally, glycoprotein isolated from this plant (RVS glycoprotein) has been shown to have inhibitory activity of <italic>T</italic>-helper type 2 (Th2) cytokines (IL-4 and -10) in bisphenol A-stimulated primary cultured mouse lymphocytes. Suppression of Th2 cytokines, especially IL-10, may promote a proinflammatory cytokine profile. Therefore, pulsatilla and rhus toxicodendron have the potential to precipitate immune-mediated response, especially following a probable viral infection as in our patient. It is possible that the proinflammatory response to probable viral prodrome was potentiated by the ingredients of the herbal supplement leading to development demyelinating pathology. Based on Naranjo algorithm, there is a possible causal relationship between Hyland Restful Legs<sup>&#xAE;</sup> and TDL.[<xref rid="ref5" ref-type="bibr">5</xref>]</p>
    <p>Due to the widespread use of herbal supplement, a thorough evaluation of their safety and efficacy is required. Physicians should consider that the immune regulatory properties of some of the herbal supplements may play a potential role in the pathogenesis of TDL, multiple sclerosis (MS), and related disorders. The investigation of these agents may help us understand the etiopathogenesis of immune mediated demyelinating conditions, including ADEM or MS.</p>
    <sec disp-level="2" id="sec2-1">
      <title>Financial support and sponsorship</title>
      <p>Nil.</p>
    </sec>
    <sec disp-level="2" id="sec2-2">
      <title>Conflict of interest</title>
      <p>There are no conflicts of interest.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostianovsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maskin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Noriega</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Soler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bonelli</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute demyelinating disease after oral therapy with herbal extracts</article-title>
          <source>Case Rep Neurol</source>
          <year>2011</year>
          <volume>3</volume>
          <fpage>141</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">21738505</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Knauth</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walter-Sack</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bonmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Storch-Hagenlocher</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: A report of two cases</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2000</year>
          <volume>69</volume>
          <fpage>516</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10990514</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <article-title>Hyland's Homeopathic. Hyland's Restful Legs Online Source Last updated 2013</article-title>
          <date-in-citation>Last accessed on 2015 Sep 11</date-in-citation>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions</article-title>
          <source>Int Immunopharmacol</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>584</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">20159051</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naranjo</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Busto</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Sellers</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sandor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A method for estimating the probability of adverse drug reactions</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>1981</year>
          <volume>30</volume>
          <fpage>239</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">7249508</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
